Inhibrx Biosciences, Inc. Common Stock (INBX) News
Latest headlines that mention INBX, newest first · each headline opens the original publisher
- Last price
- $98.19
- Day change
- +3.03%
- Next earnings
- 2026-11-13
INBX headlines
latest coverageLappe's purchase through family trusts boosts his beneficial ownership to 950,000 shares, or 6% of outstanding equity, as Inhibrx trades near $114 following a 293% gain over the past year.
INBX news alerts
Get an alert by email or push when a new headline mentions INBX.
More news
News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.